introduction
<<PREVIOUS NEXT>>

Brief Introduction of Immediate past President (2006-2008), Prof. Hiroshi Shiku

ライン
CHP Nanogel.protein Vaccines
ライン
Recent Subjects of Research:
*Protein/peptide-based therapeutic cancer vaccines with a novel antigen delivery system CHP nanogel
*Adoptive T cell therapy using retrovirus/retronectin system for tumor-specific TCR or chimeric antigen receptor (CAR) gene transduction
*Oncolytic virus immunotherapy using attenuated Herpes simplex virus
*Small molecule inhibitors of tumor-associated immune suppression
ライン
Hiroshi Shiku, M.D.



Hiroshi Shiku, M.D.


Professor, Departments of Cancer Vaccine and Immuno-gene Therapy, Mie University Graduate School of Medicine

ライン